When guideline treatment of asthma fails, consider a macrolide antibiotic.

Clicks: 303
ID: 71640
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #2 of 2 articles by views in the journal of family practice

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
This class of drugs has the potential to benefit patients with persistent, poorly controlled asthma and those with new-onset disease as an adjunct to first-line therapy.
Reference Key
hahn2019whenthe Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Hahn, David L;
Journal the journal of family practice
Year 2019
DOI
DOI not found
URL URL not found
Keywords
obesity vancomycin guideline-based dosing trough concentration

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.